These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16244356)

  • 21. Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance.
    Meeus R; Verpooten GA; De Paep R; Paelinck BP; Neels H; Cooreman S; De Doncker M; Jorens PG
    Clin Toxicol (Phila); 2008 Apr; 46(4):303-6. PubMed ID: 18363124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertrophic cardiomyopathy. Combination of beta blockers and verapamil may be risky.
    Borja J; Izquierdo I; Guindo J
    BMJ; 2006 Jul; 333(7558):97. PubMed ID: 16825239
    [No Abstract]   [Full Text] [Related]  

  • 23. Massive overdose of sustained-release verapamil: a case report and review of literature.
    Ashraf M; Chaudhary K; Nelson J; Thompson W
    Am J Med Sci; 1995 Dec; 310(6):258-63. PubMed ID: 7503108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome.
    Chinushi M; Iijima K; Tagawa M; Komura S; Furushima H; Aizawa Y
    J Electrocardiol; 2009; 42(4):367-73. PubMed ID: 19356768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular complications during treatment by verapamil. A propos of 6 cases].
    Witchitz S; Haiat R; Tarrade T; Chiche P
    Nouv Presse Med; 1975 Feb; 4(5):337-8. PubMed ID: 236544
    [No Abstract]   [Full Text] [Related]  

  • 26. Attenuation of the negative inotropic effects of metoprolol at short cycle lengths in humans: comparison with sotalol and verapamil.
    Ritchie RH; Zeitz CJ; Wuttke RD; Hii JT; Horowitz JD
    J Am Coll Cardiol; 2006 Sep; 48(6):1234-41. PubMed ID: 16979012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asystole and cardiogenic shock due to combined treatment with verapamil and flecainide.
    Buss J; Lasserre JJ; Heene DL
    Lancet; 1992 Aug; 340(8818):546. PubMed ID: 1354292
    [No Abstract]   [Full Text] [Related]  

  • 28. [Complications after intravenous administration of anti-arrhythmia agents].
    Anshelevich IuV; Dumesh SZ; Slaĭdyn' AK; Sporan VG
    Kardiologiia; 1982 Nov; 22(11):19-22. PubMed ID: 7154501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiogenic shock and major intra-ventricular block during treatment with cibenzoline].
    Bourrier P; Chennebault JM; Harry P; Broudin S; Selenou M; Alquier P
    Therapie; 1987; 42(6):561-2. PubMed ID: 3441901
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative efficacy of Univer and conventional verapamil in the control of ventricular response in atrial fibrillation.
    Hogg KJ; Hornung RS; Hillis WS
    Br J Clin Pract Suppl; 1988 Apr; 60():38-44. PubMed ID: 3151270
    [No Abstract]   [Full Text] [Related]  

  • 32. Verapamil and acute dystonia.
    Pina MA; Ara JR; Remírez A; Castiella J
    J Clin Pharm Ther; 1998 Feb; 23(1):79-80. PubMed ID: 9756116
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-cardiogenic pulmonary edema and life-threatening shock due to calcium channel blocker overdose: a case report and clinical review.
    Siddiqi TA; Hill J; Huckleberry Y; Parthasarathy S
    Respir Care; 2014 Feb; 59(2):e15-21. PubMed ID: 23674813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiogenic shock associated with verapamil in a patient with liver cirrhosis.
    Stehle G; Buss J; Eibach J; Plügge T; Lasserre JJ; Kehry I; Heene DL
    Lancet; 1990 Oct; 336(8722):1079. PubMed ID: 1977063
    [No Abstract]   [Full Text] [Related]  

  • 35. Dexmedetomidine sedation leading to refractory cardiogenic shock.
    Sichrovsky TC; Mittal S; Steinberg JS
    Anesth Analg; 2008 Jun; 106(6):1784-6. PubMed ID: 18499610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiogenic shock and major intraventricular block in treatment with cibenzoline].
    Aymard Dufour MF; Spriet Pourra C
    Therapie; 1988 May; 43(3):243-4. PubMed ID: 3420576
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose.
    Young AC; Velez LI; Kleinschmidt KC
    Resuscitation; 2009 May; 80(5):591-3. PubMed ID: 19282085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
    Stiell IG; Clement CM; Symington C; Perry JJ; Vaillancourt C; Wells GA
    Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiogenic shock resistant to sodium lactate with high-dose of cibenzoline].
    Wyss E; Karp P; Mons P; Leflon M; Wolf C
    Therapie; 1990; 45(5):455. PubMed ID: 2260048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.